Annovis Bio shares experienced a dramatic upward move following the release of encouraging clinical trial data for its Parkinson's disease...

Biotechnology firm Kezar Life Sciences is embarking on a fundamental strategic shift after encountering a significant regulatory obstacle. The U.S....

The platinum market is navigating turbulent waters following an extraordinary price surge that has defined much of the current year....

Skye Bioscience's stock is experiencing another significant downturn this week as the biotechnology firm faces a new class-action lawsuit. The...

Investors seeking reliable dividend income are facing new challenges as the Fidelity® High Dividend ETF (FDVV) demonstrates vulnerability during recent...

Investor attention turned to Aclaris Therapeutics this week following the company's presentations at the Jefferies Global Healthcare Conference. The biopharmaceutical...

Ionis Pharmaceuticals is experiencing a dramatic upward trajectory, with its stock performance capturing significant market attention. The biotech firm's impressive...

Absci finds itself navigating turbulent financial waters as the biotechnology firm grapples with plunging revenue alongside aggressive investment in its...

Market experts are growing increasingly optimistic about defense technology specialist Mercury Systems, with Wall Street sentiment shifting decisively in the...

Cava Group, the restaurant chain operator, is confronting a significant downturn as its stock value hits a fresh 52-week low....